Fortiva 1mg,2 mg, 5mg Injection
PDF Leaflet Revision Date: 26 November 2010
Clinical Summary
Quick overview from the medicine insert
Indication
Narcotic analgesic for induction and maintenance of anaesthesia.
Dosage (summary)
Adults: 0.5-1.0 u03bcg/kg/min continuous infusion; initial bolus of 1 u03bcg/kg over 30 seconds.
Onset of Action / Duration
Onset: 1-2 mins, Duration: 3-10 mins
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
- Obese patients
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; crosses placenta and appears in breast milk.
Key Drug Interactions
- CNS depressants may increase adverse effects.
- Cardiac depressants may exacerbate hypotension and bradycardia.
Contraindications
- Hypersensitivity to remifentanil or components.
- Epidural and intrathecal use.
- Use with nitrous oxide and oxygen alone at altitude.
Common side effects
- Nausea
- Vomiting
- Hypotension
- Skeletal muscle rigidity
Counselling Points
- Monitor for respiratory depression.
- Avoid driving or operating machinery post-treatment.
- Ensure alternative analgesia is available before discontinuation.
Serious warnings
- Not for sole use in general anaesthesia.
- Risk of respiratory depression.
- Dependency potential.
Important Disclaimer
The Fortiva 1mg,2 mg, 5mg Injection professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
